drugset / Trial / NCT04496479
Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
NaSequentialOpen-labelTreatment
Summary
This Phase 2a clinical trial is a dose escalation study of the safety, tolerability, and efficacy of hepatocyte transplantation into lymph nodes via endoscopic ultrasound among subjects with end-stage liver disease.
Timeline
- Start
- 2022-03-11
- Primary completion
- 2027-08-20
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LYG-LIV0001 | Cell therapy | — | Other |